STORY-TRÅD·nyheter

Weighing the risks and benefits of GLP-1 drugs for kids struggling with obesity

Childhood and teen obesity rates have soared to record highs with about 1 in 5 living with obesity. The FDA has approved GLP-1 drugs for weight loss among kids 12 and older. Dr. Rachel Pessah-Pollack explains the risks and benefits, who may be a candidate and more.